References/Publications for Basophil/Mast cell_Histamine Test of Fel d 1

Check all              

Select PubMed ID Description
1283110 Clin Exp Allergy. 1992 Dec;22(12):1100-6.

Dust from carpeted and smooth floors. V. Cat (Fel d I) and mite (Der p I and Der
f I) allergen levels in school dust. Demonstration of the basophil histamine
release induced by dust from classrooms.

Dybendal T(1), Elsayed S.


7680928 Int Arch Allergy Immunol. 1993;100(3):256-62.

Role of the major allergen (Fel d I) in patients sensitized to cat allergens.

Kleine-Tebbe J(1), Kleine-Tebbe A, Jeep S, Schou C, Løwenstein H, Kunkel G.


8232338 Mol Immunol. 1993 Nov;30(16):1529-41.

Native and recombinant Fel dI as probes into the relationship of allergen
structure to human IgE immunoreactivity.

Bond JF(1), Brauer AW, Segal DB, Nault AK, Rogers BL, Kuo MC.


8939151 J Allergy Clin Immunol. 1996 Nov;98(5 Pt 1):884-94.

Definition of the human T-cell epitopes of Fel d 1, the major allergen of the
domestic cat.

Counsell CM(1), Bond JF, Ohman JL Jr, Greenstein JL, Garman RD.


10094223
Ann Allergy Asthma Immunol. 1999 Mar;82(3):307-10.

Effect of two different types of vacuum cleaners on airborne Fel d 1 levels.

Rønborg SM(1), Poulsen LK, Skov PS, Mosbech H.


10981523 Pediatr Allergy Immunol. 2000 Aug;11(3):142-8.

The effect of high-efficiency and standard vacuum-cleaners on mite, cat and dog
allergen levels and clinical progress.

Popplewell EJ(1), Innes VA, Lloyd-Hughes S, Jenkins EL, Khdir K, Bryant TN,
Warner JO, Warner JA.


11161443 Cell Immunol. 2000 Dec 15;206(2):116-24.

Antigen-specific T cell tolerance down-regulates mast cell responses in vivo.

Treter S(1), Luqman M.


12589362 J Allergy Clin Immunol. 2003 Feb;111(2):396-401.

Allergic potency of recombinant Fel d 1 is reduced by low concentrations of
chlorine bleach.

Matsui E(1), Kagey-Sobotka A, Chichester K, Eggleston PA.


15546862 J Biol Chem. 2005 Feb 4;280(5):3208-16. Epub 2004 Nov 15.

Molecular characterization of major cat allergen Fel d 1: expression of
heterodimer by use of a baculovirus expression system.

Seppälä U(1), Hägglund P, Wurtzen PA, Ipsen H, Thorsted P, Lenhard T, Roepstorff
P, Spangfort MD.


15823449 Respir Med. 2005 May;99(5):535-44. Epub 2004 Nov 11.

Cutaneous and serological responses to cat allergen in adults exposed or not to
cats.

Liccardi G(1), Martín S, Lombardero M, D'Amato M, Barber D, D'Amato G, Cazzola M.


15898990 Clin Exp Allergy. 2005 May;35(5):657-63.

Rational design of hypoallergens applied to the major cat allergen Fel d 1.

Saarne T(1), Kaiser L, Grönlund H, Rasool O, Gafvelin G, van Hage-Hamsten M.


19076537 Allergy. 2009 Jan;64(1):172-8. doi: 10.1111/j.1398-9995.2008.01812.x. Epub 2008
Nov 28.

Targeting the MHC class II pathway of antigen presentation enhances
immunogenicity and safety of allergen immunotherapy.

Martínez-Gómez JM(1), Johansen P, Rose H, Steiner M, Senti G, Rhyner C, Crameri
R, Kündig TM.


20624641 J Allergy Clin Immunol. 2010 Aug;126(2):375-83. doi: 10.1016/j.jaci.2010.05.040.
Epub 2010 Jul 10.

Mechanisms of allergen-specific desensitization.

Uermösi C(1), Beerli RR, Bauer M, Manolova V, Dietmeier K, Buser RB, Kündig TM,
Saudan P, Bachmann MF.


21211644 J Allergy Clin Immunol. 2011 Jan;127(1):89-97, 97.e1-14. doi:
1016/j.jaci.2010.11.029.

Development and preliminary clinical evaluation of a peptide immunotherapy
vaccine for cat allergy.

Worm M(1), Lee HH, Kleine-Tebbe J, Hafner RP, Laidler P, Healey D, Buhot C,
Verhoef A, Maillère B, Kay AB, Larché M.


21411130 J Allergy Clin Immunol. 2011 Jun;127(6):1562-70.e6. doi:
1016/j.jaci.2011.02.004. Epub 2011 Mar 16.

A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis
B PreS.

Niespodziana K(1), Focke-Tejkl M, Linhart B, Civaj V, Blatt K, Valent P, van Hage
M, Grönlund H, Valenta R.


23268458 World Allergy Organ J. 2011 Jul;4(7):113-9. doi: 10.1097/WOX.0b013e3182228a39.
Epub 2011 Jul 14.

Glutaraldehyde-Modified Recombinant Fel d 1: A Hypoallergen With Negligible
Biological Activity But Retained Immunogenicity.

Versteeg SA(1), Bulder I, Himly M, van Capel TM, van den Hout R, Koppelman SJ, de
Jong EC, Ferreira F, van Ree R.


24552249 Clin Exp Allergy. 2014 Jun;44(6):882-94. doi: 10.1111/cea.12294.

Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy
vaccination and tolerance induction.

Curin M(1), Weber M, Thalhamer T, Swoboda I, Focke-Tejkl M, Blatt K, Valent P,
Marth K, Garmatiuk T, Grönlund H, Thalhamer J, Spitzauer S, Valenta R.


33651675 Am J Respir Crit Care Med. 2021 Jul 1;204(1):23-33. doi:
1164/rccm.202011-4107OC.

Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal
Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized,
Double-Blind, Placebo-controlled Clinical Trial.

Shamji MH(1), Singh I(1), Layhadi JA(1), Ito C(1), Karamani A(1), Kouser L(1),
Sharif H(1), Tang J(1), Handijiev S(1), Parkin RV(1), Durham SR(1), Kostic A(2),
Orengo JM(2), DeVeaux M(2), Kamal M(2), Stahl N(2), Yancopoulos GD(2), Wang
CQ(2), Radin AR(2).